Therapy with NEMOS®

How is NEMOS used?
t-VNS treatment uses the transcutaneous vagus nerve stimulator NEMOS.
NEMOS consists of a stimulation unit and a dedicated ear electrode.
The stimulation unit, having approximately the size of a common mobile phone, sends out the electrical impulses. It is connected with the ear electrode, which patients wear like an earphone. The impulses are transferred via ear electrode through the skin to a branch of the vagus nerve.

Patients carry out the t-VNS treatment autonomously. There is no need of hospitalization. The routine monitoring of the treatment is also accomplished on an outpatient procedure. Patients treat themselves with t-VNS in sessions lasting approximately 4 hours per day. Users can regulate and adapt the stimulation intensity according to their individual sensitivity. This can change from day to day, due to variations in skin parameters like humidity or fat content. Important is that the stimulation is noticeable. The patient should feel a tingling sensation at the contact point in the concha.

Basically, patients can carry on with their usual everyday activities during the stimulation session, so NEMOS  is easy to integrate into the patient's daily routine.

How effective is t-VNS?
Like most pharmaceutical and neuromodulatory treatments for epilepsies, therapy with NEMOS  is not an acute therapy. For patients who respond to therapy with NEMOS, the anticonvulsive effect may occur with a latency of some weeks to a few months.

Which side effects may occur?
t-VNS is a therapeutic alternative with minor side effects. An analysis of data from over 300 patients and volunteers, who participated in studies of t-VNS, showed potential side effects that include itching, dysaesthesia, and local pain at the stimulation site. These side effects usually disappear soon after stopping the stimulation.*

* Vigilance data cerbomed GmbH

t-VNS® - for treatment of drug-resistant epilepsy

Please download our brochure for health professionals.

Therapy device NEMOS®

In 2011 cerbomed received the European clearance (CE mark) for the transcutaneous vagus nerve stimulator NEMOS.

Please note: NEMOS® is not cleared or approved for use in the U.S.